RR
Ronald Richard (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Emergent BioSolutions Inc. (EBS). The largest single filing was $177K of EBS (14,884 sh × $11.90, as filed), executed Dec 5 2025. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$177K
shares × price, as filed
Last traded
Dec 5 2025
Filed Dec 9 2025
Median ADV $8.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $177K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EBS
Emergent BioSolutions Inc.
EBS · 0 buys · 1 sell
1 filing
Recent filings
EBSSALE
Emergent BioSolutions Inc.
View filing →
$177K14,884 sh × $11.90
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET